Skip to main content

Williamson Stephen's Form 4 filing

Thermo Fisher Scientific Inc. (TMO) · filed Feb 5, 2025

Accession no.
0001127602-25-003227
Filed
Feb 5, 2025
Trade date
Feb 3-4, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $11.6M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Williamson StephenCIK 0001648929Officer (Sr. VP and CFO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 3, 2025Common StockMOption exerciseAcquired+9,825$253.99+$2,495,451.7537,120.81Direct
Feb 3, 2025Common StockSSaleDisposed−9,825$593.13−$5,827,502.2527,295.81Direct
Feb 4, 2025Common StockMOption exerciseAcquired+9,825$253.99+$2,495,451.7537,120.81Direct
Feb 4, 2025Common StockSSaleDisposed−9,825$585.59−$5,753,421.7527,295.81Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 3, 2025Common StockMOption exerciseDisposed−9,825$0.00$09,825Direct
Feb 4, 2025Common StockMOption exerciseDisposed−9,825$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)